Hefei Lifeon Pharmaceutical Co Ltd (003020) — Capital Reinvestment Ratio
Hefei Lifeon Pharmaceutical Co Ltd (003020) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥667.63 Million) in capital expenditures (CN¥25.90 Million). See 003020 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hefei Lifeon Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Hefei Lifeon Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check Hefei Lifeon Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hefei Lifeon Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Hefei Lifeon Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see 003020 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | CN¥212.89 Million | CN¥118.46 Million | ▼ -28.9% |
| 2024 | 0.78x | CN¥197.53 Million | CN¥154.49 Million | ▼ -19.4% |
| 2023 | 0.97x | CN¥203.67 Million | CN¥197.54 Million | ▼ -21.0% |
| 2022 | 1.23x | CN¥200.64 Million | CN¥246.43 Million | ▲ +4.3% |
| 2021 | 1.18x | CN¥158.70 Million | CN¥186.95 Million | ▲ +261.6% |
| 2020 | 0.33x | CN¥172.49 Million | CN¥56.20 Million | ▲ +10.8% |
| 2019 | 0.29x | CN¥149.30 Million | CN¥43.90 Million | ▼ -35.0% |
| 2018 | 0.45x | CN¥64.45 Million | CN¥29.16 Million | ▼ -55.3% |
| 2017 | 1.01x | CN¥11.32 Million | CN¥11.46 Million | ▲ +368.3% |
| 2016 | 0.22x | CN¥58.99 Million | CN¥12.74 Million | ▼ -41.5% |
| 2014 | 0.37x | CN¥92.05 Million | CN¥34.01 Million | ▼ -70.4% |
| 2013 | 1.25x | CN¥35.54 Million | CN¥44.43 Million | — |